VERFAHREN ZUR KREBSBEHANDLUNG

Patent europeic · EP3288581 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3288581
Numer da la dumonda
EP16718705
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-04-2016
Publitgà
07-03-2018
Concedì
11-11-2020
La protecziun finescha il pli tard
26-04-2036
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
A61K 39/00 (2006.01)
Prioritad
GB 201507100 27.04.2015
GB 201603663 02.03.2016
GB 201603731 03.03.2016
Dumonda PCT
PCT/EP2016/059401 27.04.2016
Publicaziun PCT
WO2016/174085 03.11.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  2. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  3. 05-07-2024

    Transferì

    Owner
    Cancer Research Technology Limited, 2 Redman Place, London E20 1JQ, United Kingdom → ACHILLES THERAPEUTICS UK LIMITED, 245 Hammersmith Road, London W6 8PW, United Kingdom

    Published in Swissreg on 05.07.2024

  4. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  5. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  6. 11-11-2020

    Concedì

    Published in Swissreg on 11.11.2020

Partidas

Possessur

ACHILLES THERAPEUTICS UK LIMITED

245 Hammersmith Road, London W6 8PW, GB

Inventur

ROSENTHAL, Rachel

London E20 1JQ, GB

PEGGS, Karl

London E20 1JQ, GB

SWANTON, Charles

London E20 1JQ, GB

MCGRANAHAN, Nicholas

London E20 1JQ, GB

QUEZADA, Sergio

London E20 1JQ, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.